chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Peripheral swelling
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 713123), concerns a 65-year-old elderly female patient. The patient was allergic to amoxicillin, codeine, hydrocodone and latex. The patient's concurrent medications included ibuprofen. On 25-Aug-2017, the patient received FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: 178323, expiry date: not reported) and PNEUMOVAX (route of administration: intramuscular, anatomical location: left arm, dose, manufacturer, trade, batch, and expiry date: not reported). On 26-Aug-2017, after 1 day of vaccination, the patient reported that after receiving the PNEUMOVAX vaccine, the injection site area became red, hard, swollen. After two days of vaccination the patient's whole arm from down to the wrist became red, hard and swollen. The patient did not mention about medical or laboratory tests related to adverse event, treatment or duration of swelling. The patient had recovered from the events (injection site erythema, induration and swelling). The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Erythema, Peripheral swelling
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 713469), concerns 88-year-old, elderly female patient. The patient had no known drug allergies. On 16-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178602, expiry date: not reported) and PNEUMOVAX (dose: 1 DF, route of administration: intramuscular, anatomical location: right arm, batch number: M042785, expiry date: not reported). On 19-Sep-2017, after 3 days of vaccination, the patient developed redness and swelling on left arm (reported as stopped at elbow). At the time of the report, the patient had not recovered from the events. The reporter assessed the case as non-serious.
Age: 67.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Injection site pain, Injection site pruritus, Injection site swelling, Rash
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 05-Mar-2018 by Seqirus from VAERS (VAERS ID: 713540), concerns a 67-year-old, elderly, female patient. The patient's current condition included allergic to latex. On 17-Sep-2017, after the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179002 and expiry date: not reported) and PNEUMOVAX (route of administration: intramuscular, anatomical location: left arm, dose, manufacturer, trade, batch number, expiry date: not reported). On 19-Sep-2017, after 02 days of vaccination, the patient reported that, arm at the injection site was swollen, itchy and hurts (as reported) and developed rash on her legs. The patient reported that the possible reaction due to latex allergy. The patient was advised to go to the hospital. The patient reported she was going to take BENADRYL if it helps. At the time of the report, the outcome of the event was unknown.
Sex: F
Vaccine: FLUA3, PNC13
Symptoms: Injection site erythema, Injection site inflammation, Injection site rash
Clinical narrative: This is a spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 713668), concerns a 74-year-old, elderly, female patient. The patient's medical history was not reported. The patient had no known allergies. The patient's concomitant medications included TRAZODONE, amlodipine and FLUOXETINE. On 18-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179001 and expiry date: not reported) and non-company suspect product PREVNAR 13 (dose: 1 DF, route of administration: intramuscular, anatomical location: left arm, batch number: R73811 and expiry date: not reported).On 19-Sep-2017, after 1 day of vaccination, the patient had redness and inflamed rash of approximately 6 inches around her upper left arm. It was reported that, no findings were reported by the doctor for the events. At the time of this report, the patient had not yet recovered from the events. The reporter assessed the events as non-serious.
Sex: F
Vaccine: FLUA3
Symptoms: Injection site swelling
Clinical narrative: This is spontaneous case, reported by Other Health Professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 713768), concerns a 75-year-old elderly female patient. The patient's current conditions included diabetes, high blood pressure, penicillin (as reported). The patient's historical conditions included high cholesterol, thyroid, glaucoma. On 15-Sep-2017, the patient received FLUAD vaccine (dose: 0.5ml (1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: 179002). On the same day, after vaccination, the patient had a big swelling at the injection site right after one take out of the needle. At the time of this report, the patient had not yet recovered from the event. The reporter assessed the case as non-serious.
Age: 12.0
Sex: M
Vaccine: FLUA3
Symptoms: Headache
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 713923), concerns a 12-year-old, adolescent, male patient. The patient had no relevant medical history and no known allergies or current illness. On 19-Sep-2017, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179002 and expiry date: not reported). On the same day, after the administration of vaccine, the patient experienced headache. It was reported that, the patient's mother had advised the patient to take ibuprofen and had monitored patient's activity. At the time of this report, the patient had recovered from the event- headache. The reporter assessed this case as non-serious.
Sex: F
Vaccine: FLUA3
Symptoms: Administration site pain, Administration site swelling
Clinical narrative: This is spontaneous case, reported by other health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERW ID: 713932), concerns a 9-year-old female child patient. The patient's current conditions included ADHD (attention deficit/hyperactivity disorder) and no know allergies were reported. The patient's concomitant medications included clonidine HCL and CONCERTA. On 19-Sep-2017, the patient (under age) was administered with FLUAD TIV (dose: 0.5ml (1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: 179002). On the same day, after vaccination the patient had swelling and soreness at the administration site. The patient's mother advised to apply a cold compress, treated with ibuprofen and child activity was monitored. The outcome of the events (administration site pain, administration site swelling) was recovered. The reporter assessed the case as non-serious.
Age: 66.0
Sex: M
Vaccine: FLUA3, IPV, PNC13, TDAP, VARZOS
Symptoms: Nausea, Pyrexia
Clinical narrative: This is spontaneous case, reported by Other Health Professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 714396), concerns a 66-year-old elderly male patient. On 20-Sep-2017, the patient received FLUAD (dose: 0.5ml, route of administration: unknown, anatomical location: right arm, batch number: 179001) and non-company suspect vaccines PREVNAR 13 (dose: 1 as reported, route of administration: unknown, anatomical location: left arm, batch number: S31257), BOOSTRIX (dose: unknown as reported, route of administration: unknown, anatomical location: left arm, batch number: 9XJ5L), ZOSTAVAX (dose: 1 as reported, route of administration: unknown, anatomical location: left arm, batch number: N020942). On 21-Sep-2017, 1 day, after vaccine administration, the patient experienced nausea and fever. The outcome of the events was unknown. The reporter assessed the case as non-serious.
Age: 53.0
Sex: F
Vaccine: FLUA3
Symptoms: Computerised tomogram, Headache, Laboratory test
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 05-Mar-2018 by Seqirus from VAERS (VAERS ID: 715078), concerns a 53-year-old, elderly, female patient. The patient's current condition included diabetes and high blood pressure. The patient's concomitant medications included CRESTOR, ZETIA, Metformin ER, Lisinopril, SOLIQUA 100/33, Omega, ZANTAC, 3 ethyl and ester for an unknown indication. On 01-Sep-2017, after the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: UI845AA (as reported) and expiry date: not reported). On 23-Sep-2017, after 22 days of vaccination, the patient had extreme headache. On 24-Sep-2017, the patient was taken to emergency room (ER) and performed 2 computed tomography (CT) scan and laboratory tests. On 26-Sep-2017, the patient was taken to physician office and performed laboratory tests. The patient received pain and inflammation medications. At the time of the report, the outcome of the event not recovered.
Sex: M
Vaccine: FLUA3, PPV
Symptoms: Injection site pain, Injection site urticaria
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 715343), concerning a 74-year-old, elderly male patient. The patient's current condition included: pre-hypertension and mild cold. The patient's concomitant medications included: Pantoprazole, Aspirin, Losartan, Potassium, Vitamin B12, Folic acid, Simvastatin, AREDS2 and multiple vitamin for an unknown indication. On 27-Sep-2017, the patient was administered with non-company suspect drug PNEUMOVAX (route of administration: intramuscular, anatomical location: right arm, dose, batch number, expiry date: not reported). On 28-Sep-2017, next morning, the patient developed some soreness on the arm at the site of the flu shot (injection site pain). Then later, she developed three small pimple-sized hives around the site of injection. At the time of this report, the patient felt normal (except for a very small lingering cold) and was fine. The patient was still recovering from the events injection site pain and injection site urticaria. The reporter assessed the event as non-serious.
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Erythema, Hypersensitivity
Clinical narrative: This is a spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 715617), concerns a 70-year-old, elderly, female patient. The patient had no medical history and allergy. The patient did not receive any concomitant medication. On 01-Sep-2017 (reported as Friday), the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179523, and expiry date: not reported) and non-company suspect product PNEUMOVAX (dose: 1 DF, route of administration: intramuscular, anatomical location: right arm, batch number: N019348 and expiry date: not reported). On the same day, after the vaccination, the patient developed a big red mark on her right arm. Since, she received the pneumococcal vaccine, she suspected as she had an allergic reaction. The patient was advised to use ice pack and BENADRYL. It was reported that, other than the events patient was fine. At the time of this report, the outcome of the event was not reported. The reporter assessed the events as non-serious.
Age: 80.0
Sex: F
Vaccine: FLUA3, VARZOS
Symptoms: Injection site pain
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 715869), concerning an 80-year-old, elderly female patient. The patient had no current illness. The patient's concomitant medications included: SPIRIVA, gabapentin and VENTOLIN. On 25-Sep-2017, the patient was administered with FLUAD (dose: 0.5 ml (reported as 1 dose), route of administration: unknown, anatomical location: left arm, batch number: 178323, expiry date: not reported) and non-company suspect drug ZOSTAVAX (dose: 1 DF, route of administration: subcutaneous, anatomical location: left arm, batch number: N020939, expiry date: not reported). On the same day, the patient experienced severe pain in arm where both the vaccines were administered. It was reported that, the patient applied ice and heat as well as took ibuprofen. The patient was recommended to use TYLENOL and to consult provider if no improvement was seen in few days. At the time of this report, the outcome of the event (injection site pain) was not reported. The reporter assessed the event as non-serious. Non-significant case correction received 06-Mar-2018: Case comment was corrected (added sentence co-suspect, ZOSTAVAX was also administered to the patient on the same day as the FLUAD.
Age: 74.0
Sex: F
Vaccine: FLUA3
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 715880), concerns a 74-year-old elderly female patient. The patient was allergic to penicillin. On 27-Sep-2017, the patient was administered with FLUAD (dose: 0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178302A, expiry date: not reported). On the same day after the administration of vaccine, the patient experienced soreness and redness of one-inch size at the injection area. No lab data was reported. The outcome of the events was not recovered. The reporter assessed this case as non-serious.
Sex: M
Vaccine: FLUA3, PNC13
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 715925), concerns a 75-year-old, elderly male patient. The patient's medical history and current condition were not reported. On 20-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: unknown, anatomical location: right arm, batch number: 179523, expiry date: not reported) and PREVNAR 13 (dose: 1 dose, route of administration: unknown, anatomical location: left arm, batch number: R75238 (as reported), expiry date: not reported). On 24-Sep-2017, after 4 days of vaccination, the patient developed typical reaction including slight swelling, soreness and redness that covered half of the upper arm, where PREVNAR was administered. It was reported that, these events prevented him from getting allergy shots for a couple of days. The outcome of the events was unknown. The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLUA3, PNC13
Symptoms: Urticaria
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 716644), concerns a 66-year-old, elderly, female patient. The patient's current condition included cardiac issues and the patient was allergic to medications, food and environment (since on an unspecified date). The concomitant medications were unknown. On 29-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179301 and expiry date: not reported). On the same day, the patient was also administered with non-company suspect product, PREVNAR 13 (dose: 1 (as reported), route of administration: intramuscular, anatomical location: right arm, batch number: S39564 and expiry date: not reported). On 30-Sep-2017 (Saturday), after 1 day of vaccination, the patient developed hives bilaterally on face. It was reported that, the patient had several allergies which were not positive to that reaction due to either vaccine. The patient went to physician for follow-up. At the time of the report, the patient had not recovered from the event (urticaria). The reporter assessed the case as non-serious.
Age: 83.0
Sex: F
Vaccine: FLUA3
Symptoms: Erythema, Nausea, Pain in extremity
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 716757), concerns an 83-year-old, elderly female patient. The patient's current conditions included hypertension, osteoporosis, allergy to penicillin and cephalosporins. However, current illness was given as none. The concomitant medications included spironolactone/hydrochlorothiazide, raloxifene and flurazepam. On 02-Oct-2017, the patient was administered with FLUAD (dose: 0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179201, expiry date: not reported). On the same day, after vaccination, the patient developed severe soreness in arm and redness down the arm to the elbow. The events continued till 06-Oct-2017, but decreased in severity. The patient also experienced nausea for a few days after receiving vaccine. At the time of the report, the patient had recovered from the events. The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Erythema, Localised infection, Pain, Peripheral swelling
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 716865), concerns a 67-year-old female patient. The patient's current condition included hypertension however the patient was not receiving any concomitant medications. On 03-Oct-2017, the patient was not received FLUAD (TIV) (dose: 1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: 178901 and expiry date: not reported). On the same day, the patient had received PNEUMOVAX (dose: 1 DF, route of administration: intramuscular, anatomical location: left arm, batch number: N022303 and expiry date: not reported) one centimeter below the FLUAD shot. On 04-Oct-2017, the very next day of vaccination, the patient's arm was swollen all the way to her elbow. The patient developed body ache and pain after receiving the vaccines. On consulting a doctor, the patient was information that the arm was infected. The patient received a shot at the clinic and was prescribed with BACTRIM DS, (BID (twice daily) for 10 days). It was reported that swelling of the arm was reduced however the arm was still red. The patient was advised to use over the counter ibuprofen and hydrocortisone cream. The outcome of the events, erythema, infection and pain was not recovered, and peripheral swelling was recovering. The reporter assessed this case as non-serious.
Age: 66.0
Sex: F
Vaccine: FLUA3, PNC13
Symptoms: Injection site inflammation, Injection site reaction, Neck pain, Pain in extremity, Peripheral swelling
Clinical narrative: This spontaneous case, reported by Other Health Professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 717877), concerns a 66-year-old elderly female patient. The patient's current condition included hypertension and historical drug was lisinopril. On 29-Sep-2017, the patient was administered with FLUAD (dose: 0.5ml (1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: 178623) and PREVNAR 13 (dose: 1 as reported, route of administration: intramuscular, anatomical location: right arm, batch number: 558702 as reported). On 1-Oct-2017, the patient developed inflammation on the right arm (reported as where getting pneumonia vaccination) which appeared as a large red rash about the size of a tennis ball. The patient developed the rash two days after getting the immunizations. Subsequently, rash has grown in its size and pain in the area, up through the right side of the neck. The patient had no trouble in breathing. The patient was advised to take OTC (over the counter) NSAID (non-steroidal anti-inflammatory drugs) to alleviate the pain and reduce the swelling in her arm. Additionally, ice pack and hydrocortisone cream were advised. The patient was followed up for 6 hours after her initial report to the pharmacy. It was reported that, the pain was slightly getting better with the use of OTC NSAID. The outcome of the events was unknown. The reporter assessed the case as non-serious.
Age: 66.0
Sex: F
Vaccine: FLUA3, PNC13
Symptoms: Rash erythematous
Clinical narrative: This spontaneous case, reported by Other Health Professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 717877), concerns a 66-year-old elderly female patient. The patient's current condition included hypertension and historical drug was lisinopril. On 29-Sep-2017, the patient was administered with FLUAD (dose: 0.5ml (1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: 178623) and PREVNAR 13 (dose: 1 as reported, route of administration: intramuscular, anatomical location: right arm, batch number: 558702 as reported). On 1-Oct-2017, the patient developed inflammation on the right arm (reported as where getting pneumonia vaccination) which appeared as a large red rash about the size of a tennis ball. The patient developed the rash two days after getting the immunizations. Subsequently, rash has grown in its size and pain in the area, up through the right side of the neck. The patient had no trouble in breathing. The patient was advised to take OTC (over the counter) NSAID (non-steroidal anti-inflammatory drugs) to alleviate the pain and reduce the swelling in her arm. Additionally, ice pack and hydrocortisone cream were advised. The patient was followed up for 6 hours after her initial report to the pharmacy. It was reported that, the pain was slightly getting better with the use of OTC NSAID. The outcome of the events was unknown. The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Erythema, Inflammation, Pain in extremity
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 717886), concerns an 83-year-old, elderly female patient. On 24-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179302, expiry date: not reported) and PNEUMOVAX (dose: unknown, route of administration: intramuscular, anatomical location: left arm, batch number: N019348, expiry date: not reported). On the same day, after vaccination, the patient developed upper arm redness (reported as bright red), soreness and inflammation. On an unspecified date, the patient consulted the physician for the events. The outcome of the events was unknown. The reporter assessed the case as non-serious. Non-significant case correction received on 20-Mar-2018: Case comment was corrected.
Age: 63.0
Sex: F
Vaccine: FLUA3
Symptoms: Musculoskeletal pain
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 717900), concerns a 63-year-old adult female patient. The patient's historical condition included chronic fatigue syndrome. The patient had no known allergies. On 28-Sep-2017, the patient was administered with FLUAD (TIV) (dose:0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178602, expiry date: not reported). On the same day after vaccination, the patient experienced severe shoulder pain and went to emergency room, where NAPROSYN was given. At the time of this report, the outcome of the event was unknown. The reporter assessed this case as non-serious.
Age: 89.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Injection site bruising, Injection site erythema, Respiratory tract congestion, Rhinitis
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 718049), concerning an 89-year-old, elderly female patient. The patient's medical history and concomitant medications were not reported. On 04-Oct-2017, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179301, expiry date: not reported). On the same day, the patient was administered with non-company suspect drug PNEUMOVAX (dose: 1 DF, route of administration: intramuscular, anatomical location: right arm, batch number: N019348, expiry date: not reported). On the same day of immunization, the patient had congestion and rhinitis. In addition, the patient had redness and bruising of arm spreading beyond the injection site. The patient was treated with over the counter (OTC) remedies. The redness had calmed down within 48 hours. However, the symptoms were still bothersome. OTC treatment was continued after 48 hours. At the time of this report, the outcome of the events was unknown. The reporter assessed the case as non-serious. Significant case correction received 20-Mar-2018: Causality for the event 'Rhinitis' was changed from not related to related. Case comment changed accordingly.
Sex: F
Vaccine: FLUA3
Symptoms: Erythema
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 718135), concerns 81-year-old, elderly, female patient. The patient was allergic to latex. The patent's relevant medical history was not reported and had no current illnesses. On 04-Oct-2017, the patient was administered with FLUAD (dose: 0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178901, expiry date: not reported). On 06-Oct-2017, 2 days after vaccination, the patient experienced erythema from shoulder to elbow. The outcome of the event was unknown. The reporter assessed this case as non-serious.
Sex: F
Vaccine: FLUA3
Symptoms: Chills, Feeling abnormal, Feeling cold, Gait disturbance, Headache
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 718218), concerning a 70-year-old, elderly female patient. The patient's historical condition: fibromyalgia. Current condition included: osteoarthritis. The patient was allergic to BUSPAR and BACTRIM. Concomitant medications included: LEXAPRO, CLORAZEPATE, Levothyroxine, Losartan, Cetirizine, CELECOXIB, Aspirin and Vitamin D3. On 02-Oct-2-17, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179001, expiry date: not reported). On 03-Oct-2017, the patient woke up freezing under her covers and was shaking. The patient tried to get warmer but realized that, had fever and couldn't get warm. Upon touching her face with her hands, patient felt it was burning up, due to fever. Patient took TYLENOL for fever. The patient got out of bed, but was shaking violently from the chills more than before and could hardly walk. After taking TYLENOL, fever reduced and later took two doses again. The patient was still wobbly from the chills and eventually went back to sleep. On 04-Oct-2017, the next morning, patient woke up with headache and felt awful and took 2 more doses of TYLENOL and felt okay by the next evening. The patient had no lab data performed. The patient had recovered from all the events. The reporter assessed the case as non-serious. Non-significant case correction received on 20-Mar-2018: Narrative was corrected (the word she was replaced with patient). Non-significant case correction on 20-Mar-2018: VAERS ID was added in vaccine administration section [in product tab]. No changes were made in the narrative.
Sex: F
Vaccine: FLUA3
Symptoms: Pyrexia, Skin warm, Tremor
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 718218), concerning a 70-year-old, elderly female patient. The patient's historical condition: fibromyalgia. Current condition included: osteoarthritis. The patient was allergic to BUSPAR and BACTRIM. Concomitant medications included: LEXAPRO, CLORAZEPATE, Levothyroxine, Losartan, Cetirizine, CELECOXIB, Aspirin and Vitamin D3. On 02-Oct-2-17, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179001, expiry date: not reported). On 03-Oct-2017, the patient woke up freezing under her covers and was shaking. The patient tried to get warmer but realized that, had fever and couldn't get warm. Upon touching her face with her hands, patient felt it was burning up, due to fever. Patient took TYLENOL for fever. The patient got out of bed, but was shaking violently from the chills more than before and could hardly walk. After taking TYLENOL, fever reduced and later took two doses again. The patient was still wobbly from the chills and eventually went back to sleep. On 04-Oct-2017, the next morning, patient woke up with headache and felt awful and took 2 more doses of TYLENOL and felt okay by the next evening. The patient had no lab data performed. The patient had recovered from all the events. The reporter assessed the case as non-serious. Non-significant case correction received on 20-Mar-2018: Narrative was corrected (the word she was replaced with patient). Non-significant case correction on 20-Mar-2018: VAERS ID was added in vaccine administration section [in product tab]. No changes were made in the narrative.
Age: 67.0
Sex: F
Vaccine: FLUA3, FLUA3
Symptoms: Injection site pain, Mobility decreased
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 718260), concerns a 67-year-old, elderly female patient. The patient's current condition included hypertension and allergy to amlodipine, sulfa drugs, macrolide antibiotics, Lisinopril, carvedilol, however current illness was reported as unknown. The patient's concomitant medications included, ORACEA, losartan, CELEBREX, SYNTHROID, HCTZ. On 06-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: 1797401 (as reported), expiry date: not reported). On the same day, after vaccination, the patient developed pain and tenderness of the arm, which subsequently, progressed to excruciating pain. The pain improved slightly but had no strength in arm and could not raise it. At the time of this report, the patient had not recovered from the events. The reporter assessed the case as non-serious.
Age: 67.0
Sex: F
Vaccine: FLUA3, FLUA3
Symptoms: Asthenia, Mobility decreased, Pain in extremity, Tenderness
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 718260), concerns a 67-year-old, elderly female patient. The patient's current condition included hypertension and allergy to amlodipine, sulfa drugs, macrolide antibiotics, Lisinopril, carvedilol, however current illness was reported as unknown. The patient's concomitant medications included, ORACEA, losartan, CELEBREX, SYNTHROID, HCTZ. On 06-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: 1797401 (as reported), expiry date: not reported). On the same day, after vaccination, the patient developed pain and tenderness of the arm, which subsequently, progressed to excruciating pain. The pain improved slightly but had no strength in arm and could not raise it. At the time of this report, the patient had not recovered from the events. The reporter assessed the case as non-serious.
Age: 91.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Erythema, Skin warm
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 718321), concerns a 91-year-old, elderly, female patient. The patient's current condition included, Alzheimer's and the patient allergic to penicillin (since an unspecified date). On 01-Oct-2017, the patient was administered with FLUAD (dose: 0.5 ml (1 as reported), route of administration: injection, anatomical location: left arm, batch number: 178901 and expiry date: not reported). On the same day, the patient was administered with non-company suspect product, PNEUMOVAX (dose: 1 (as reported), route of administration: intramuscular, anatomical location: left arm, batch number: M022085 and expiry date: not reported). On the same day, after vaccination, the patient developed redness and warm from shoulder to elbow. The patient went to physician and treated with antibiotics. At the time of the report, the outcome of the events (erythema and skin warm) was not recovered. The reporter assessed the case as non-serious.
Age: 71.0
Sex: F
Vaccine: FLUA3
Symptoms: Cough, Deafness unilateral, Fatigue, Headache, Impaired driving ability
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 718398) concerns a 71-year-old, elderly, female patient. It was reported that, a couple of years ago, the patient had angioplasty. The historical drugs included FLAGYL and PLAVIX for an unknown indication (on an unspecified date). The current condition included high blood pressure (on an unspecified date) and the patient was allergic to sulfa and statin drugs (from an unspecified date). The concomitant medications included Baby aspirin, NORVASC, PLETAL, VALIUM, and FLONASE (on an unspecified date). On 27-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml), anatomical location: left arm, batch number: 179102, route of administration and expiry date: not reported). On the same day, 3 hours of vaccination, the patient experienced coughing. It was reported that, the patient woke up with fever of 103, deafness on right ear, left ear also felt echo sound. The patient received TYLENOL for fever, which had started to break down. There is significant ringing in the ear and the patient felt too sick. So, she was not able to drive for 3 days. On 30-Sep-2017, went to emergency room, the physician told her that, the ear drum was dropped and treated with antibiotics, which did not help her to get out. On 05-Oct-2017, the patient went to primary care physician (PCP) and received shot of ROCEPHIN and no improvement was seen. After the shot, the fever went down. It was also reported that, patient had sharp headaches at the time of consultation to doctor and now her ringing in ears and fatigue got worsen. Her follow-up with doctor was scheduled on Thursday (as reported). At the time of this report, the patient had recovered from the event fever, had not recovered from tinnitus and fatigue and the outcome of the events deafness right ear, impaired driving ability, headache and cough was unknown. The reporter assessed the case as non-serious. Significant case correction received 20-Mar-2018: As determined causality of the events deafness unilateral, tinnitus and impaired driving ability was corrected from related to not related and case comment was amended. Non-significant case correction received 20-Mar-2018: Sentence reformation was done in narrative (from "As determined causality of the events deafness unilateral, tinnitus and impaired driving ability was corrected from not related to related and case comment was amended" to "As determined causality of the events deafness unilateral, tinnitus and impaired driving ability was corrected from related to not related and case comment was amended.").
Age: 71.0
Sex: F
Vaccine: FLUA3
Symptoms: Malaise, Pyrexia, Tinnitus, Tympanic membrane disorder
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 718398) concerns a 71-year-old, elderly, female patient. It was reported that, a couple of years ago, the patient had angioplasty. The historical drugs included FLAGYL and PLAVIX for an unknown indication (on an unspecified date). The current condition included high blood pressure (on an unspecified date) and the patient was allergic to sulfa and statin drugs (from an unspecified date). The concomitant medications included Baby aspirin, NORVASC, PLETAL, VALIUM, and FLONASE (on an unspecified date). On 27-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml), anatomical location: left arm, batch number: 179102, route of administration and expiry date: not reported). On the same day, 3 hours of vaccination, the patient experienced coughing. It was reported that, the patient woke up with fever of 103, deafness on right ear, left ear also felt echo sound. The patient received TYLENOL for fever, which had started to break down. There is significant ringing in the ear and the patient felt too sick. So, she was not able to drive for 3 days. On 30-Sep-2017, went to emergency room, the physician told her that, the ear drum was dropped and treated with antibiotics, which did not help her to get out. On 05-Oct-2017, the patient went to primary care physician (PCP) and received shot of ROCEPHIN and no improvement was seen. After the shot, the fever went down. It was also reported that, patient had sharp headaches at the time of consultation to doctor and now her ringing in ears and fatigue got worsen. Her follow-up with doctor was scheduled on Thursday (as reported). At the time of this report, the patient had recovered from the event fever, had not recovered from tinnitus and fatigue and the outcome of the events deafness right ear, impaired driving ability, headache and cough was unknown. The reporter assessed the case as non-serious. Significant case correction received 20-Mar-2018: As determined causality of the events deafness unilateral, tinnitus and impaired driving ability was corrected from related to not related and case comment was amended. Non-significant case correction received 20-Mar-2018: Sentence reformation was done in narrative (from "As determined causality of the events deafness unilateral, tinnitus and impaired driving ability was corrected from not related to related and case comment was amended" to "As determined causality of the events deafness unilateral, tinnitus and impaired driving ability was corrected from related to not related and case comment was amended.").
Age: 67.0
Sex: F
Vaccine: FLUA3, VARZOS
Symptoms: Injection site erythema, Injection site paraesthesia, Injection site warmth
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 718411), concerns a 67-year-old, elderly female patient. The patient's current conditions included diabetes, high cholesterol and had no known allergy. The concomitant medications included lisinopril, metformin, allopurinol, atorvastatin. On 07-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179103, expiry date: not reported) and ZOSTAVAX (dose: 1 (as reported), route of administration: subcutaneous, anatomical location: right arm, batch number: N020852, expiry date: not reported). On 08-Oct-2017, after 1 day of vaccination, the patient developed redness and warmth at the site of injection. On 09-Oct-2017, the patient visited the pharmacy and was advised with heat compression. The patient was asked to draw a line around the red area to identify whether redness spread or not. On 10-Oct-2017, the patient visited the pharmacy as the redness spread beyond the outline. The patient decided to see medical attention, as he started to experiencedtingling at the site of injection. The outcome of the event was unknown. The reporter assessed the case as non-serious.
Age: 65.0
Sex: F
Vaccine: FLUA3
Symptoms: Urticaria
Clinical narrative: This is a spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 719971), concerns a 65-year-old, elderly, female patient. It was reported that, whenever patient experienced a sinus infection she always developed hives (similar to the reaction to suspect product). On 10-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179402 and expiry date: not reported). On 12-Oct-2017, after 2 days of vaccination, the patient developed hives on her arms and torso. She denied SOB (shortness of breath), wheezing and angioedema. It was reported that, whenever patient experienced a sinus infection she always developed the similar hives. The patient was prescribed to take BENADRYL (orally for 1 time) and suggested to monitor and to go to ER (emergency room) if signs and symptoms worsened. At the time of this report, the outcome of the events was unknown. The reporter assessed the event as non-serious.
Age: 67.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: This spontaneous case, reported by Other Health Professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 719974), concerns a 67-year-old elderly female patient. The patient did not have any known medical history or current illness. It was unknown whether the patient was taking any medications at the time of vaccination. On 11-Oct-2017, the patient was administered with FLUAD (dose: 0.5ml (N/A as reported), route of administration: intramuscular, anatomical location: left arm, batch number: 179502) and PNEUMOVAX (dose: N/A as reported, route of administration: intramuscular, anatomical location: left arm, batch number: N013541 (as reported). On 12-Oct-2017, a day after vaccination, the patient had redness and swelling on the inside of upper left arm. At the time of this report, the patient had not yet recovered from the events. The reporter assessed the case as non-serious.
Age: 1.33
Sex: F
Vaccine: FLUA3, HIBV, MMRV
Symptoms: Urticaria
Clinical narrative: This spontaneous case, reported by Other Health Professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 720201), concerns a 16-months-old (1.42 years) female infant. The patient's historical condition included eczema and current condition included coxsackie colde. On 11-Oct-2017, the patient was administered with FLUAD (dose: 0.5ml, (UNK as reported), route of administration: not reported, anatomical location: left gluteus, batch number: not reported), HIBERIX (dose: UNK as reported, route of administration: not reported, anatomical location: left leg, batch number: not reported) and PROQUAD (dose: UNK as reported, route of administration: not reported, anatomical location: left gluteus, batch number: not reported). On 12-Oct-2017, 23 hrs after multiple vaccines were administered, the patient developed hives on the face. It was reported that, a call was made to the doctor's office, they suggested to give BENADRYL. At the time of this report, the patient had not yet recovered from the event. The reporter assessed the case as non-serious.
Age: 74.0
Sex: F
Vaccine: FLUA3
Symptoms: Arthralgia
Clinical narrative: This is a spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 720359), concerns a 74-year-old, elderly, female patient. The patient's historical condition, allergy, current illness and concomitant medications were not reported. On 08-Oct-2017, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: 179301 and expiry date: not reported). On 11-Oct-2017, after 3 days of vaccination, the patient experienced achy joints. At the time of this report, the outcome of the event was unknown. The reporter assessed the event as non-serious.
Age: 77.0
Sex: M
Vaccine: FLUA3
Symptoms: Injection site erythema
Clinical narrative: This is a spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 20-MAR-2018 by Seqirus from VAERS (VAERS ID: 720546), concerns a 77-year-old, elderly, male patient. The patient's current condition included high blood pressure (since an unspecified date). The patient's concomitant medications included Atorvastatin and Metoprolol. On 20-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178901 and expiry date: not reported). On an unspecified date, the patient developed red spot at injection site and went to the physician office. At the time of this report, the patient had not yet recovered from the event. The reporter assessed the event as non-serious.
Age: 57.0
Sex: M
Vaccine: FLUA3
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: This spontaneous case, reported by Other Health Professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 720552), concerns a 57-year-old adult male patient. The patient's medical history and current illness was not reported. On 05-Oct-2017, the patient was administered with FLUAD (dose: 0.5ml (unk as reported), route of administration: intramuscular and anatomical location: left arm, batch number: 179402). The patient was administered with the vaccine at the inappropriate age (below 65 years) (coded as drug administered to patient of inappropriate age). The outcome of the events was unknown. The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLUA3
Symptoms: Eye swelling, Swelling face
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 720577), concerns a 74-year-old elderly female patient. The patient was allergic to morphine. The patient's concomitant medication included CELEBREX, VIVELLE-DOT, Propranolol, Metoprolol, ELIQUIS, Diltiazem, ZUBSOLV, Losartan/HCTZ for an unknown indication. On 13-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179401, expiry date: not reported). On 14-Oct-2017, after 1 day of vaccination, the patient experienced swelling of left side of face and it was lumpy. It was reported that, the patient's eyes were swollen. At the time of this report, the outcome of the events was not recovered. The reporter assessed this case as non-serious.